GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

KYNB · Jun 30, 2025

KYNTRA BIO, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0000950170-25-106549General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.96% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

940.80% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-97.34% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

286.57% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

93.69% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-894.07% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

435.09% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

138.95% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20264/5 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 0.58%
Current: 0.96%
Delta: 0.38%

Cash Generation Increased

Previous: 99.27%
Current: 940.80%
Delta: 841.53%

Growth Decreased

Previous: -95.10%
Current: -97.34%
Delta: -2.24%

Inventory Pressure Increased

Previous: 115.19%
Current: 286.57%
Delta: 171.38%

Margin Increased

Previous: 90.80%
Current: 93.69%
Delta: 2.89%

Profitability Decreased

Previous: -544.72%
Current: -894.07%
Delta: -349.34%

R And D Intensity Increased

Previous: 334.98%
Current: 435.09%
Delta: 100.11%

Sbc Intensity Increased

Previous: 104.13%
Current: 138.95%
Delta: 34.82%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · KYNB Fundamental State →Transitioned To · KYNB Fundamental State →Transitioned To · KYNB CAPEX_INTENSITY_INCREASED →Transitioned To · KYNB CASH_GENERATION_INCREASED →Transitioned To · KYNB GROWTH_DECREASED →Transitioned To · KYNB INVENTORY_PRESSURE_INCREASED →Transitioned To · KYNB MARGIN_INCREASED →Transitioned To · KYNB PROFITABILITY_DECREASED →Transitioned To · KYNB R_AND_D_INTENSITY_INCREASED →Transitioned To · KYNB SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.